02664nam 2200529Ia 450 991081601690332120230721015940.092-9021-714-6(CKB)2670000000033938(EBL)538063(OCoLC)694342017(SSID)ssj0000432091(PQKBManifestationID)11269973(PQKBTitleCode)TC0000432091(PQKBWorkID)10477478(PQKB)11560688(MiAaPQ)EBC538063(Au-PeEL)EBL538063(CaPaEBR)ebr10392232(EXLCZ)99267000000003393820090311d2009 uy 0engur|n|---|||||txtccrMeasuring transparency to improve good governance in the public pharmaceutical sectorLebanon[electronic resource]Cairo, Egypt World Health Organization, Regional Office for the Eastern Mediterraneanc20091 online resource (79 p.)Description based upon print version of record.92-9021-651-4 Includes bibliographical references.COVER; TITLE; COPYRIGHT; Contents; Foreword; Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Lebanon; 3. Methodology; 4. Results and data presentations; 5. Data analysis and discussion; 6. Recommendations; 7. Conclusions; 8. Resource documents; AnnexesThis report presents the results of a transparency assessment carried out in Lebanon. It gives a comprehensive assessment of the level of transparency and the level of vulnerability to corruption within the six primary functions of the pharmaceutical sector - registration, inspection, promotion, selection, procurement and distribution of medicines. The methodology provides both qualitative and quantitative information. Three national investigators, selected by the Ministry of Health, collected data by conducting a series of interviews with 50 carefully selected key informants. The informPharmaceutical industryStandardsLebanonPharmaceutical policyLebanonPharmaceutical industryStandardsPharmaceutical policy331World Health Organization.Regional Office for the Eastern Mediterranean.MiAaPQMiAaPQMiAaPQBOOK9910816016903321Measuring transparency to improve good governance in the public pharmaceutical sector3982904UNINA